Cargando…
Pharmacogenomic technologies: a necessary "luxury" for better global public health?
BACKGROUND: Pharmacogenomic technologies aim to redirect drug development to increase safety and efficacy of individual care. There is much hope that their implementation in the drug development process will help respond to population health needs, particularly in developing countries. However, ther...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175439/ https://www.ncbi.nlm.nih.gov/pubmed/21864366 http://dx.doi.org/10.1186/1744-8603-7-30 |